Evidence of Independent Origin of Multiple Tumors From Patients With Prostate Cancer-Reference-Cited by-同舟云学术

Evidence of Independent Origin of Multiple Tumors From Patients With Prostate Cancer

Published:1998-02-04 Issue:3 Volume:90 Page:233-237
ISSN:0027-8874
Container-title:JNCI: Journal of the National Cancer Institute
language:en
Short-container-title:

Author:

Cheng Liang,Pretlow Thomas G.,Abdul-Karim Fadi W.,Kung Hsing-Jien,Tsai Min-Lung,Dawson Deborah V.,Linehan W. Marston,Song Sang-Yong,Park Won-Sang,Moon Young-Wan,Emmert-Buck Michael R.,Liotta Lance A.,Zhuang Zhengping

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Oncology

Link

http://academic.oup.com/jnci/article-pdf/90/3/233/18048657/90-3-233.pdf

Reference38 articles.

1. Cancer Statistics, 1996;Parker;CA Cancer J Clin,1996

2. An adjustment to the 1997 estimate for new prostate cancer cases;Wingo;CA Cancer J Clin,1997

3. Age and racial distribution of prostatic intraepithelial neoplasia;Sakr;Eur Urol,1996

4. Pathologic features of hereditary prostate cancer;Bastacky;J Urol,1995

5. The distribution of residual cancer in radical prostatectomy specimens in stage A prostate cancer;Greene;J Urol,1991

Cited by 185 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular Pathology of Prostate Cancer;Clinics in Laboratory Medicine;2024-06

2. Integrative multi-region molecular profiling of primary prostate cancer in men with synchronous lymph node metastasis;Nature Communications;2024-05-21

3. Value of perilesional biopsies in multiparametric magnetic resonance imaging-targeted biopsy and systematic biopsy in detection of prostate cancer: results of a prospective, non-randomized, surgeon-blinded study;World Journal of Urology;2024-05-06

4. Prostate cancer: Molecular aspects, consequences, and opportunities of the multifocal nature;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-03

5. Visium spatial transcriptomics reveals intratumor heterogeneity and profiles of Gleason score progression in prostate cancer;iScience;2023-12